342 filings
Page 4 of 18
8-K
1xs0a64s lta9wsbs
21 May 14
Other Events
12:00am
8-K
54j3y
7 May 14
ARIAD Reports First Quarter 2014 Financial Results and Development Progress
12:00am
8-K
9pd5topme36
1 May 14
Departure of Directors or Certain Officers
12:00am
8-K
r5f9tyk3
24 Mar 14
ARIAD Announces Initiation of Pivotal Phase 2 ALTA Trial of AP26113 in Patients with Non-Small Cell Lung Cancer
12:00am
8-K
ccgxd2wf6x qz
25 Feb 14
ARIAD Reports 2013 Financial Results and Outlines Key Objectives for 2014
12:00am
8-K
pz5g8bqjed act
21 Feb 14
Nomination and Standstill Agreement
12:00am
8-K
psublb fqsjxg2
5 Feb 14
Other Events
12:00am
8-K
x7kqe
17 Jan 14
Other Events
12:00am
8-K
zhkn7
20 Dec 13
ARIAD Announces U.S. Resumption of Marketing and Commercial Distribution of Iclusig (ponatinib) in Refractory Philadelphia-Positive Leukemias
12:00am
8-K
q0tazery334fj
22 Nov 13
ARIAD Announces Positive Opinion by the European Medicines Agency on the Continued Availability of Iclusig in Patients with Leukaemias
12:00am
8-K
6eelea 146qn1qq6w7
12 Nov 13
ARIAD Reports Third Quarter 2013 Financial Results and Announces Significant Expense Reduction
12:00am
8-K/A
tzgupwiq 1u0v
5 Nov 13
Entry into a Material Definitive Agreement
12:00am
8-K
pmai 78sxzg
1 Nov 13
Entry into a Material Definitive Agreement
12:00am
8-K
5ol6wfa17djbif
31 Oct 13
ARIAD Announces Temporary Suspension of Iclusig Marketing in the United States
12:00am
8-K
qxemm 4o7a32z4gw
18 Oct 13
ARIAD Announces Discontinuation of the Phase 3 Epic Trial of Iclusig in Patients with Newly Diagnosed Chronic Myeloid Leukemia
12:00am
8-K
k6eur8tk6bb
9 Oct 13
ARIAD Announces Changes in the Clinical Development Program of Iclusig
12:00am
8-K
8g74lkzy
30 Sep 13
ARIAD Presents Updated Phase 1/2 Data on AP26113 in Patients with Non-Small Cell Lung Cancer
12:00am
8-K
orm 4psg9xelo
18 Sep 13
Entry into a Material Definitive Agreement
12:00am
8-K
rjtr65m2tv
4 Sep 13
Interim Analysis of Efficacy in Newly Diagnosed Patients With Chronic Myeloid Leukemia Expected in Third Quarter of 2014
12:00am
8-K
6teq tqtci5sh
7 Aug 13
ARIAD Reports Second Quarter 2013 Financial Results and Development Progress
12:00am